268 related articles for article (PubMed ID: 17288034)
21. Updated antiretroviral guidelines available.
AIDS Alert; 2004 Jun; 19(6):72. PubMed ID: 15272454
[No Abstract] [Full Text] [Related]
22. The 15th annual HIV drug guide.
Posit Aware; 2011; 23(2):21-50. PubMed ID: 21796851
[No Abstract] [Full Text] [Related]
23. Behind the frontline. A doctor looks at combos & side effects.
Vázquez E
Posit Aware; 2003; 14(1):63-4. PubMed ID: 12630377
[No Abstract] [Full Text] [Related]
24. Antiretroviral therapy roundup from CROI. Report on newer drugs in development and some already approved drugs.
Berry J
Posit Aware; 2008; 19(3):20-3. PubMed ID: 18724440
[No Abstract] [Full Text] [Related]
25. Drug interactions need more attention.
AIDS Treat News; 2001 Jan; (377):3-4. PubMed ID: 11862807
[No Abstract] [Full Text] [Related]
26. The eleventh annual HIV drug guide.
Posit Aware; 2007; 18(1):21-49. PubMed ID: 17288032
[No Abstract] [Full Text] [Related]
27. Helping your antiretrovirals help you. Things to consider when choosing what goes in the tank.
Ngo M
Posit Aware; 2006; Spec No():15-8. PubMed ID: 17233081
[No Abstract] [Full Text] [Related]
28. [Interactions of antiretroviral drugs].
Fuertes A; Otero MJ
Med Clin (Barc); 1999 Jun; 113(3):94-102. PubMed ID: 10464744
[No Abstract] [Full Text] [Related]
29. Rilpivirine (Edurant)--a new drug for HIV infection.
Med Lett Drugs Ther; 2011 Aug; 53(1371):67-8. PubMed ID: 21860365
[No Abstract] [Full Text] [Related]
30. A dose of unintended consequences. A quick guide to HIV drug interactions.
Mehta S; Vázquez E
Posit Aware; 2010; 21(2):48-51. PubMed ID: 20524349
[No Abstract] [Full Text] [Related]
31. [How should pharmacists assist in combination therapy? Pharmaceutical care of HIV patients].
Schake D
Pharm Unserer Zeit; 2001; 30(3):240-6. PubMed ID: 11400674
[No Abstract] [Full Text] [Related]
32. News from the 12th annual CROI.
Emery C
Surviv News (Atlanta Ga); 2005; 16(3):6. PubMed ID: 16106550
[No Abstract] [Full Text] [Related]
33. Getting the most out of treatment.
Learned J
Posit Aware; 2005; Spec No():2. PubMed ID: 16335471
[No Abstract] [Full Text] [Related]
34. New drugs in development.
Proj Inf Perspect; 2000 Mar; (29):8-9. PubMed ID: 12769052
[TBL] [Abstract][Full Text] [Related]
35. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
36. FDA notifications. FDA grants approval for raltegravir.
AIDS Alert; 2009 Apr; 24(4):46-8. PubMed ID: 19382366
[No Abstract] [Full Text] [Related]
37. [Standards, trends and challenges in HIV medicine].
Paukstadt W
MMW Fortschr Med; 2000; 142(3 Suppl):2. PubMed ID: 10893945
[No Abstract] [Full Text] [Related]
38. Drug interactions in HIV-positive patients initiated on protease inhibitor therapy.
Preston SL; Postelnick M; Purdy BD; Petrolati J; Aasi H; Stein DS
AIDS; 1998 Jan; 12(2):228-30. PubMed ID: 9468380
[No Abstract] [Full Text] [Related]
39. [Multidrug combination therapy in HIV infection treatment: "monotherapy has died, long live multidrug therapy!"].
Cabarcos Ortíz de Barrón A; Martínez Vázquez JM
An Med Interna; 1998 Mar; 15(3):121-4. PubMed ID: 9567420
[No Abstract] [Full Text] [Related]
40. Anti-HIV agents. Still searching for a cure.
TreatmentUpdate; 2005; 17(6):1-2. PubMed ID: 17228473
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
